Roy, Jean-Philippe
Devarajan, Prasad http://orcid.org/0000-0002-7847-8552
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (P50DK096418)
Article History
Received: 17 August 2019
Accepted: 30 September 2019
First Online: 11 November 2019
Compliance with Ethical Standards
:
: Dr. Devarajan is a co-inventor on submitted patents for the use of NGAL as a biomarker for kidney injury.
: Work quoted in this review that was completed in the authors’ laboratory was funded by grants fromthe NIH(P50DK096418).